rs11516156

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_014694.4(ADAMTSL2):​c.91-182T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.305 in 151,940 control chromosomes in the GnomAD database, including 7,842 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.30 ( 7842 hom., cov: 33)

Consequence

ADAMTSL2
NM_014694.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.44

Publications

1 publications found
Variant links:
Genes affected
ADAMTSL2 (HGNC:14631): (ADAMTS like 2) This gene encodes a member of the ADAMTS (a disintegrin and metalloproteinase with thrombospondin motifs) and ADAMTS-like protein family. Members of the family share several distinct protein modules, including a propeptide region, a metalloproteinase domain, a disintegrin-like domain, and a thrombospondin type 1 (TS) motif. Individual members of this family differ in the number of C-terminal TS motifs, and some have unique C-terminal domains. The protein encoded by this gene lacks the protease domain, and is therefore of a member of the the ADAMTS-like protein subfamily. It is a secreted glycoprotein that binds the cell surface and extracellular matrix; it also interacts with latent transforming growth factor beta binding protein 1. Mutations in this gene have been associated with geleophysic dysplasia. [provided by RefSeq, Feb 2009]
ADAMTSL2 Gene-Disease associations (from GenCC):
  • geleophysic dysplasia 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • Ehlers-Danlos syndrome
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 9-133537223-T-A is Benign according to our data. Variant chr9-133537223-T-A is described in ClinVar as Benign. ClinVar VariationId is 680523.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.473 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014694.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADAMTSL2
NM_014694.4
MANE Select
c.91-182T>A
intron
N/ANP_055509.2
ADAMTSL2
NM_001145320.2
c.91-182T>A
intron
N/ANP_001138792.1Q86TH1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ADAMTSL2
ENST00000651351.2
MANE Select
c.91-182T>A
intron
N/AENSP00000498961.2Q86TH1
ADAMTSL2
ENST00000393061.7
TSL:1
c.418-182T>A
intron
N/AENSP00000376781.3B1B0D4
ADAMTSL2
ENST00000354484.8
TSL:1
c.91-182T>A
intron
N/AENSP00000346478.4Q86TH1

Frequencies

GnomAD3 genomes
AF:
0.305
AC:
46275
AN:
151822
Hom.:
7836
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.187
Gnomad AMI
AF:
0.433
Gnomad AMR
AF:
0.217
Gnomad ASJ
AF:
0.353
Gnomad EAS
AF:
0.431
Gnomad SAS
AF:
0.489
Gnomad FIN
AF:
0.444
Gnomad MID
AF:
0.320
Gnomad NFE
AF:
0.348
Gnomad OTH
AF:
0.286
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.305
AC:
46306
AN:
151940
Hom.:
7842
Cov.:
33
AF XY:
0.311
AC XY:
23123
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.187
AC:
7733
AN:
41436
American (AMR)
AF:
0.217
AC:
3316
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.353
AC:
1225
AN:
3466
East Asian (EAS)
AF:
0.431
AC:
2221
AN:
5150
South Asian (SAS)
AF:
0.489
AC:
2358
AN:
4818
European-Finnish (FIN)
AF:
0.444
AC:
4690
AN:
10570
Middle Eastern (MID)
AF:
0.327
AC:
96
AN:
294
European-Non Finnish (NFE)
AF:
0.348
AC:
23656
AN:
67916
Other (OTH)
AF:
0.292
AC:
617
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1617
3234
4852
6469
8086
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
472
944
1416
1888
2360
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.225
Hom.:
631
Bravo
AF:
0.274

ClinVar

ClinVar submissions as Germline
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.019
DANN
Benign
0.52
PhyloP100
-2.4
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11516156; hg19: chr9-136402345; API